| Heather M. Hamel |
Heather M. Hamel is Chief Legal Officer & General Counsel at Invivo Therapeutics Holdings Corp.
In her past career Ms. Hamel was Research Associate at the University of Wisconsin.
Ms. Hamel received a graduate degree from Harvard University and an undergraduate degree from the University of Wisconsin-Stevens Point. |
| Richard Toselli |
Currently, Richard Toselli holds the position of President, CEO, Director & Chief Medical Officer at Invivo Therapeutics Holdings Corp. and President, CEO, Chief Medical Officer & Director at InVivo Therapeutics Corp. (a subsidiary of Invivo Therapeutics Holdings Corp.). He is also on the board of Spinex, Inc.
Dr. Toselli previously held the position of Chief Medical Officer of Cochlear Ltd., Chief Medical & Technology Officer at Medtronic Plc, Chief Medical & Technology Officer at Covidien Surgical Solutions Group, Vice President-Evidence Based Medicine at Johnson & Johnson Worldwide VP-Clinical Evidence at DePuy Spine, Inc. and Director-Medical Affairs at DePuy Synthes Spine, Inc. (both are subsidiaries of Johnson & Johnson), Vice President-Global Medical Affairs at Sanofi Corp., Assistant Professor at Brown University, Associate Professor at the University of Vermont and Director-Spine Center at The University of North Carolina at Charlotte.
Dr. Toselli received a doctorate from Brown University, an undergraduate degree from Providence College and an MBA from Kenan-Flagler Business School. |
| C. Ann Merrifield |
C. Ann Merrifield is a businessperson who has been at the helm of 5 different companies. Currently, she is Chairman at Invivo Therapeutics Holdings Corp. and Chairman at InVivo Therapeutics Corp. (a subsidiary of Invivo Therapeutics Holdings Corp.). She is also on the board of 11 other companies.
She previously occupied the position of Partner at Bain & Co., Inc., President, Chief Executive Officer & Director at PathoGenetix, Inc., President of Genzyme Biosurgery Corp., President of Genzyme Genetics, Inc., Senior VP-Business Excellence Initiative at Genzyme Corp. and Investment Officer at Aetna Life & Casualty Co.
Ms. Merrifield received an undergraduate degree and a graduate degree from the University of Maine and an MBA from Tuck School of Business at Dartmouth. |
| Richard C. Christopher |
Currently, Richard C. Christopher is Chief Financial Officer & Treasurer of Invivo Therapeutics Holdings Corp.
He previously was Chief Operating & Financial Officer at Caliber Imaging & Diagnostics, Inc., CFO, Secretary, Treasurer & Executive VP at iCAD, Inc., Chief Financial Officer & Vice President-Finance at DUSA Pharmaceuticals, Inc. and Manager-North American Cost Accounting at W. R. Grace & Co.-Conn.
Richard C. Christopher received a graduate degree from Suffolk University and an undergraduate degree from Bentley University. |
| Richard John Roberts |
Currently, Richard John Roberts occupies the position of Chief Scientific Officer of New England Biolabs, Inc. He is also on the board of InVivo Therapeutics Corp. and Invivo Therapeutics Holdings Corp.
In the past Dr. Roberts occupied the position of Assistant Director at Cold Spring Harbor Laboratory, Inc.
Dr. Roberts received an undergraduate degree and a doctorate from The University of Sheffield. |
| Robert J. Rosenthal |
Robert J. Rosenthal is a businessperson who has been the head of 14 different companies and presently occupies the position of Chairman & Chief Innovation Officer at Taconic Biosciences, Inc., Chairman for Taconic Biosciences A (a subsidiary of Taconic Biosciences, Inc.), Chairman at Trace Bioanalytics LLC, Chairman at Care Everywhere LLC and Chairman of Galvanic Applied Sciences, Inc. He is also on the board of 7 other companies.
He previously occupied the position of Chairman of Safeguard Scientifics, Inc., Chairman for Sensor Innovations, Inc., President & Chief Executive Officer of Alseres Pharmaceuticals, Inc., President at Nicolet Instrument Corp., President & Chief Executive Officer of Magellan Discovery Technologies LLC, President-Instrument Division & Senior VP at Perkin Elmer Corp., Chairman & Chief Executive Officer for IMI Intelligent Medical Implants AG, President, Chief Executive Officer & Director at TekCel, Inc., President, Chief Executive Officer & Director at Magellan Diagnostics, Inc. and President & Chief Executive Officer of Magellan Biosciences, Inc.
Dr. Rosenthal received a doctorate from Emory University, an MBA from Stanford University, a graduate degree from The State University of New York and an undergraduate degree from the University of Maryland. |
| Christina Morrison |
Presently, Christina Morrison holds the position of Chief Financial Officer at Physicians Endoscopy LLC. She is also on the board of InVivo Therapeutics Corp., Invivo Therapeutics Holdings Corp. and Angel Flight East and Member-Overseers Board at Tuck School of Business at Dartmouth.
In her past career Christina Morrison was Managing Director at Health Care Group, Inc., Senior Vice President-Business at Merck & Co., Inc., Senior Vice President-Finance of Aramark, Chief Financial Officer & Senior Vice President for Wyeth Pharmaceuticals LLC and Managing Director-Health Care Group at Deutsche Bank Corp.
Christina Morrison received an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from Tuck School of Business at Dartmouth. |
| Daniel Robert Marshak |
Currently, Daniel Robert Marshak holds the position of Chief Technology Officer for PHASE Scientific International Ltd. and Advisor at Prime Movers Lab LLC. Dr. Marshak is also on the board of 8 other companies.
In the past Dr. Marshak held the position of Chief Technology Officer & VP-Biotechnology at Cambrex Corp., Chief Scientific Officer & Senior Vice President at Revvity, Inc., Chief Scientific Officer & Senior Vice President at Osiris Therapeutics, Inc., Chief Scientific Officer at Ferghana Partners, Inc., Assistant Professor at The State University of New York and Senior Staff Investigator at Cold Spring Harbor Laboratory, Inc.
He received an undergraduate degree from Harvard University and a doctorate from The Rockefeller University. |
